Serum interferon-gamma-induced protein 10 levels can help predict sarcopenia development in patients with primary hepatocellular carcinoma: A retrospective cohort study
Patients with sarcopenia at baseline more frequently presented with low IP-10 levels than those without. Contrarily, the group without sarcopenia at baseline and with high baseline IP-10 levels and high IP-10 ratios at 1 year were more likely to develop sarcopenia after 3 years. Monitoring of IP-10 levels may enable the identification of groups prone to develop sarcopenia in patients with HCC.
Authors
- Hitomi Takada (ORCID: https://orcid.org/0000-0003-2101-0454)
- Shinya Maekawa (ORCID: https://orcid.org/0000-0002-5643-9472)
- Shinichi Takano (ORCID: https://orcid.org/0000-0002-3364-828X)
- Takashi Yoshida (ORCID: https://orcid.org/0000-0003-1119-312X)
- Shōji Kobayashi (ORCID: https://orcid.org/0000-0002-8496-3685)
- Leona Osawa (ORCID: https://orcid.org/0000-0002-4159-6467)
- Yasuyuki Komiyama
- Masaru Muraoka (ORCID: https://orcid.org/0000-0002-6559-9785)
- Yuichiro Suzuki (ORCID: https://orcid.org/0000-0002-3070-7387)
- Nobuyuki Enomoto
- Mitsuaki Sato
Institutions
- University of Yamanashi (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1371/journal.pone.0309852
- Citations
- 1
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 1.16